201 related articles for article (PubMed ID: 36154569)
21. Tannins and vascular complications of Diabetes: An update.
Laddha AP; Kulkarni YA
Phytomedicine; 2019 Mar; 56():229-245. PubMed ID: 30668344
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress in diabetic nephropathy.
Kashihara N; Haruna Y; Kondeti VK; Kanwar YS
Curr Med Chem; 2010; 17(34):4256-69. PubMed ID: 20939814
[TBL] [Abstract][Full Text] [Related]
23. Fish oil emulsion supplementation might improve quality of life of diabetic patients due to its antioxidant and anti-inflammatory properties.
Laubertová L; Koňariková K; Gbelcová H; Ďuračková Z; Muchová J; Garaiova I; Žitňanová I
Nutr Res; 2017 Oct; 46():49-58. PubMed ID: 28893413
[TBL] [Abstract][Full Text] [Related]
24. The role of inflammatory cytokines in diabetes and its complications.
King GL
J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007
[TBL] [Abstract][Full Text] [Related]
25. Hyperglycemia-Induced Immune System Disorders in Diabetes Mellitus and the Concept of Hyperglycemic Memory of Innate Immune Cells: A Perspective.
Lisco G; Giagulli VA; De Pergola G; Guastamacchia E; Jirillo E; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2022; 22(4):367-370. PubMed ID: 34561995
[TBL] [Abstract][Full Text] [Related]
26. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
Elmarakby AA; Sullivan JC
Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
[TBL] [Abstract][Full Text] [Related]
27. Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages.
Son S; Hwang I; Han SH; Shin JS; Shin OS; Yu JW
J Biol Chem; 2017 Dec; 292(50):20437-20448. PubMed ID: 29051224
[TBL] [Abstract][Full Text] [Related]
28. [The role of carbonyl stress in the development of diabetic complications].
Makk-Merczel K; Szarka A
Orv Hetil; 2019 Oct; 160(40):1567-1573. PubMed ID: 31565977
[TBL] [Abstract][Full Text] [Related]
29. Effects of Diabetes Mellitus-Related Dysglycemia on the Functions of Blood-Brain Barrier and the Risk of Dementia.
Wątroba M; Grabowska AD; Szukiewicz D
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373216
[TBL] [Abstract][Full Text] [Related]
30. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
Yang P; Feng J; Peng Q; Liu X; Fan Z
Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
[TBL] [Abstract][Full Text] [Related]
31. The cellular and molecular mechanisms of diabetic complications.
King GL; Brownlee M
Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
[TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end-products and the progress of diabetic vascular complications.
Jakus V; Rietbrock N
Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
[TBL] [Abstract][Full Text] [Related]
33. Plasma glycation adducts and various RAGE isoforms are intricately associated with oxidative stress and inflammatory markers in type 2 diabetes patients with vascular complications.
Adeshara KA; Bangar N; Diwan AG; Tupe RS
Diabetes Metab Syndr; 2022 Mar; 16(3):102441. PubMed ID: 35247657
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress and diabetic complications.
Giacco F; Brownlee M
Circ Res; 2010 Oct; 107(9):1058-70. PubMed ID: 21030723
[TBL] [Abstract][Full Text] [Related]
35. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.
Obrosova IG; Julius UA
Curr Vasc Pharmacol; 2005 Jul; 3(3):267-83. PubMed ID: 16026323
[TBL] [Abstract][Full Text] [Related]
36. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.
Ceriello A
Diabetes Care; 2003 May; 26(5):1589-96. PubMed ID: 12716823
[TBL] [Abstract][Full Text] [Related]
37. Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats.
Pal PB; Sinha K; Sil PC
PLoS One; 2014; 9(9):e107220. PubMed ID: 25233093
[TBL] [Abstract][Full Text] [Related]
38. Role of Innate Immunity and Oxidative Stress in the Development of Type 1 Diabetes Mellitus. Peroxiredoxin 6 as a New Anti-Diabetic Agent.
Novoselova EG; Glushkova OV; Khrenov MO; Lunin SM; Novoselova TV; Parfenuyk SB
Biochemistry (Mosc); 2021 Dec; 86(12):1579-1589. PubMed ID: 34937537
[TBL] [Abstract][Full Text] [Related]
39. Diabetic retinopathy and the role of Omega-3 PUFAs: A narrative review.
Georgiou M; Prokopiou E
Exp Eye Res; 2023 Jun; 231():109494. PubMed ID: 37149278
[TBL] [Abstract][Full Text] [Related]
40. Innate immunity in diabetes and diabetic nephropathy.
Wada J; Makino H
Nat Rev Nephrol; 2016 Jan; 12(1):13-26. PubMed ID: 26568190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
